SCHEMBL14158979

SCHEMBL14158979

CC(C)(C)N1CC(n2cc(I)c3c(Br)ccnc32)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14158619 0.70 CDK5 (0.35) —
SCHEMBL18393434 0.67 MTOR (0.47) —
SCHEMBL18393435 0.67 MTOR (0.47) —
SCHEMBL14158908 0.66 KDR (0.32) —
SCHEMBL13857873 0.65 ADK (0.45) —
SCHEMBL24650664 0.59 MTOR (0.54) —
SCHEMBL30674367 0.59 L3MBTL1 (0.46) —
SCHEMBL31701095 0.59 L3MBTL1 (0.36) —
SCHEMBL18508880 0.59 L3MBTL1 (0.36) —
SCHEMBL15753342 0.58 DGAT1 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2717694-A1 NOVEL COMPOUNDS GlaxoSmithKline Intellectual Property Limited (GB) 2014-04-16 — — EP disclosed
WO-2012170752-A1 NOVEL COMPOUNDS GLAXO WELLCOME MANUFACTURING PTE LTD (SG) 2012-12-13 — — WO disclosed
Send feedback